Fig. 1From: Impact of the number of repeated inhalations and patient characteristics on the residual amount of inhaled laninamivir octanoate hydrate dry powder in pediatric patients with influenzaResidual amount of laninamivir dry powder after repeated inhalation of laninamivir DPI. Box plots represent the median with range. Statistical analyses were performed using the Wilcoxon test with Bonferroni correction. *: P < 0.05, NS: not significantBack to article page